1
Department of Physics, Universitat Jaume I, Castellón de la Plana, Spain, 2 National Center of Biotechnology (CNB-CSIC), Campus Universidad Autónoma de Madrid, Madrid, Spain, 3 School of Biological Sciences, Division of Structural and Computational Biology, Nanyang Technological University, Singapore, Singapore. Coronaviruses (CoV) are vertebrate pathogens that cause common colds, bronchiolitis and acute respiratory distress syndrome. In fact, their relevance increased when the causative agent of the severe acute respiratory syndrome (SARS) was identified as a CoV. CoV E protein is a small transmembrane protein of between 76-109 amino acids in length that modulates coronavirus morphogenesis, tropism and virulence [1] . We sought to elucidate the role of E protein IC activity in virus pathogenesis by combining our knowledge of residues essential for E protein ion conductivity with the manipulation of SARS-CoV genome. To test the contribution of E protein IC activity in virus pathogenesis, two recombinant mouseadapted SARS CoVs, each containing one single amino acid mutation that suppressed ion conductivity, were engineered. After serial infections, mutant viruses, in general, incorporated compensatory mutations within E gene that rendered active ion channels. Furthermore, IC activity conferred better fitness in competition assays, suggesting that ion conductivity represents an advantage for the virus. Interestingly, mice infected with viruses displaying E protein IC activity, either with the wild-type E protein sequence or with the revertants that restored ion transport, rapidly lost weight and died. In contrast, mice infected with mutants lacking IC activity, which did not incorporate mutations within E gene during the experiment, recovered from disease and most survived. We have shown that SARS-CoV E protein IC activity is a virulence determinant.
[1] DeDiego, M.L., et al 2008. Virology 376, 379-389. [2] Verdiá-Báguena C., et al. 2012. Virology. 432: 485-494 .
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Divalent Copper Compound as Inhibitory Agent of Influenza A Kelly L. McGuire, Nathan A. Gordon, Roger G. Harrison, David D. Busath. Physiology and Developmental Biology, BYU, Provo, UT, USA. Influenza A virus (IAV) exhibits a high mutation frequency. Mutations in the proton channel M2 have created substantial IAV drug resistance to previously effective drugs, such as amantadine (AMT), along with its analogs. The main drug-resistant variation in the M2 proton channel, which has become ubiquitous in humans, is the mutation S31N. Divalent copper has previously been shown, using in vitro assays involving SSNMR and Xenopus oocytes, to bind and block wild type M2 at the His37 selectivity filter. Here we report initial tests of the hypothesis that, given the essential, conserved nature of the selectivity filter, a complex consisting of copper bound to an amantadine derivative might serve as a broad-spectrum anti-IAV drug. The EC 50 of AMT, two AMT analogs, CuCl 2 2H 2 O, and four previously published Cu 2þ complexes were tested for antiviral activity against the California/07/2009 (H1N1) IAV strain containing the S31N M2 proton channel in viral mini-plaque assays and for M2(22-62, S31N)-mediated proton transport block in liposomes. A novel, AMT-based divalent copper compound, NAG 107, emerged as a plausible lead with an EC 50 of 2.91 5 0.29 mM in the viral mini-plaque assay and 4.5 5 0.6 mM in the liposome assay, 21-fold and 11-fold better than amantadine in these assays, respectively.
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Insights on Molecular Determinants of hERG K D Channel Inhibition: Design, Synthesis, and Biological Evaluation of Lubeluzole Derivatives Roberta Gualdani 1 , Maria Maddalena Cavalluzzi 2 , Francesco Tadini-Buoninsegni 1 , Maria Rosa Moncelli 1 , Giovanni Lentini 2 . 1 Department of Chemistry, University of Florence, Sesto F.no (FI), Italy, 2 Department of Medicinal Chemistry, University of Bari, Bari, Italy. Drug-induced block of 'Human ether-a-go-go-related Gene' (hERG) K þ channels is the main reason of long QT syndrome, a disorder of cardiac repolarization which may lead to sudden death due to ventricular fibrillation. This side effect has been the most frequent cause for drug withdrawal from the pharmaceutical market. For this reason, understanding the molecular determinants of hERG channel inhibition is an interesting strategy to avoid the cardiotoxicity of drugs. Lubeluzole, a neuroprotective compound, has been associated with the acquired long QT syndrome and ventricular arrhythmias; however its effects on the hERG K þ channel have not been described to date. Thus, the molecular determinants for lubeluzole action on hERG channel were studied using the patch clamp technique. We found that lubeluzole and its enantiomer are highly potent inhibitors of hERG current with an IC50 value of around 10 nM (no stereoselectivity observed). Moreover we observed that hERG inhibition by lubeluzole is time-and voltage-dependent. In fact lubeluzole causes a negative shift in the voltage dependence of hERG current activation and accelerates tail current deactivation, suggesting that it preferentially blocks the activated state of the channel. To go further in details, we synthesized a series of lubeluzole congeners designed to explore the role of lipophilicity and electronic distribution. Structural variations were designed on the basis of the indications gained by quantum-mechanical calculations run at several DFT levels. For each compound we determined the relative hERG affinity and the statedependent mechanism, to evaluate how specific modification of drug structure affected hERG binding interaction. Main SAR results will be presented. monitor and regulate intracellular calcium and are ideal pharmacological targets for immunosuppression, fibroproliferative disorders, hypertension and various neurological diseases. However, the development of drugs specifically for these medically relevant channels faces serious challenges because there is no available crystal structure that could be used for structure-assisted drug design. We used the Kv1.2-Kv2.1 channel structure (pdb id: 2R9R) as a template to generate a homology model of the KCa3.1 channel transmembrane region using the Rosetta modeling method. Docking of small molecules that are known to block KCa3.1 channel currents using Rosetta generated structural models of channel -drug complexes that can be validated using experimental approaches. Here we report the validation of the binding sites for the dihydropyridine nifedipine predicted by Rosetta's lowest energy stimulation of the KCa3.1 channel complex. We used a combination of site-directed mutagenesis and electrophysiological patch-clamp recording to test the identified amino acid residues located between the pore lining S5 and S6 segment. Blocking of the KCa3.1 channel by nifedipine was reduced by altering the side chains at positions L209, T212 and V278 to either alanine or valine, with T212 the most affected residue. Bulkier side-chain change to phenylalanine confirmed T212 as the main interacting site for nifedipine without compromising the channel's affinity for TRAM-34. Thus, by correctly identified the interaction of the dihydropyridine nifedipine with the KCa3.1 channel complex, Rosetta models can be used to understand the molecular mechanism of action of KCa channel blockers and gating modulators and assist with drug design efforts.
2944-Pos
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GBR-12909: Potent Blocker of Peak and Late Nav1.5 Currents Carlos Obejero-Paz, James Kramer, Andrew Bruening-Wright, Antonio Lacerda, Arthur Brown. ChanTest Corporation, Cleveland, OH, USA. GBR-12909 (vanoxerine) is a potent highly selective dopamine transporter antagonist. It was initially developed for treatment of Parkinson's disease and while safe in man, lacked efficacy. Although a potent hERG blocker, the drug exhibits multiple ion channel effects including frequencydependence. The drug effectively terminated induced, sustained atrial fibrillation (AF) and atrial flutter in a canine model of sterile pericarditis. Subsequently the drug terminated AF in a Phase 2B ascending dose trial. Previous in vitro measurements used protocols that did not address the issue of the late Nav1.5 current which is important in understanding safety of a potent hERG blocker. Peak and late sodium currents were measured in HEK-293 cells stably expressing the human Nav1.5 channel. Peak currents were measured using a step-ramp protocol consisting of a 40 ms step to À15 mV (where the peak current was measured), a 180 ms step to þ30 mV and a 200 ms ramp to the holding potential of À80 mV (1 Hz stimulating frequency). The effect of the drug was parameterized with a single binding isotherm having an IC 50 of 29 5 3 nM (95% CI: 22-37) and a Hill coefficient of 0.91 5 0.10 (95% CI: 0.68-1.18) (seven cells, three concentrations). We also evaluated the effect of GBR-19209 on currents increased using the sea-anemone toxin ATX-II as a surrogate of the late sodium current. The calculated IC 50 and Hill coefficients from five cells and five concentrations were 93 5 9 nM (95% CI: 7-117) and 1.57 5 0.24 (95% CI: 1.05-2.67), respectively. Thus, GBR-12909 block is at least sixty times more potent than ranolazine's (IC 50 ¼ 6 mM).The combination of potent peak and late sodium block may explain the antiarrhythmic and safe profile of the drug. (TMDs) to favor the open channel configuration. Lately, another CFTR potentiator NPPB was reported to enhance CFTR activity through a modus operandi that exploits the ATP hydrolysis-driven, non-equilibrium gating mechanism unique to CFTR. It is however puzzling that NPPB can also increase the activity of non-hydrolytic G551D-CFTR, the third most common pathogenic mutation. We therefore set forth to unravel the mechanism of NPPB using VX-770 as a reference. Once the blocking effect of NPPB was corrected, we found that NPPB and VX-770, when applied alone, increased the Po of G551D-CFTR by 6.9 5 0.8 (n ¼ 12) and 9.3 5 1.4 (n ¼ 21) folds respectively. Once these two reagents were applied together, however, the Po was increased by 28.98 5 7.6 fold (n¼ 10), less than the expected magnitude (~60-fold) if NPPB and VX-770 work independently. Hence, NPPB only increases the Po of G551D-CFTR by 3.7 5 0.4 fold (n ¼ 9) in the presence of VX-770. Similarly, a much reduced enhancement (4.8 5 1.8 fold, n ¼ 5) of the Po by VX-770 in the presence of NPPB was seen. Interestingly, we also observed that VX-770 effectively potentiates a CFTR mutant with its second nucleotide-binding domain completely removed (i.e., dNBD2), whereas NPPB has virtually no effect (n ¼ 12). These results can be explained by a gating model featuring an energetic coupling between opening/closing of the gate in TMDs where VX-770 binds and dimerization/dissociation of NBDs where NPPB acts on.
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''Use Dependence'' Without a Ball and Chain -Inhibition of Bacterial Sodium Channels by m-Contoxins Rocio K. Finol-Urdaneta, Denys McMaster, Robert J. French. Physiology & Biophysics, University of Calgary, Calgary, AB, Canada. ''Use-'' or ''state-'' dependent block of voltage-gated sodium channels is characteristic of therapeutic agents used to moderate electrical activity in pathologically hyperactive tissues and combat certain forms of epilepsy, cardiac arrhythmia, myotonia, and pain. Externally acting Na channel pore blockers are not commonly used as therapeutic drugs, but intraperitoneal m-conotoxin (mCTX) KIIIA can act as an effective analgesic against inflammatory pain in mice, at concentrations that do not cause obvious systemic side effects (Zhang et al 2007 J Biol Chem 42:30699) . This action appears to result from highly specific targeting to neuronal Na channels, without essential reliance on the use-dependent potency that contributes to the efficacy of clinical local anesthetics. mCTXs, although highly selective among closely related eukaryotic Na channels, have recently been found to block bacterial Nav channels with high affinity (Chen & Chung 2012 Biophys J 102:483; Finol-Urdaneta et al 2013 Biophys J 104:136a) . In addition, the block was potentiated at more depolarized holding potentials. Here, we explore the dependence of mCTX PIIIA block of NaChBac and NavSp1 on varying patterns of conditioning depolarization. Briefly, in the low picomolar range, PIIIA application was associated with faster inactivation decay during a test depolarization, and block of the peak current. The speeding of inactivation precedes the block of current following PIIIA application, and this kinetic effect was obvious at more negative holding potentials than was the decrease in peak current. In NaChBac, both activation and inactivation were shifted in the hyperpolarizing direction bỹ 25-30 mV in the presence of 5pM PIIIA. The data suggest that PIIIA binding is conformation dependent, with high affinity for non-conducting, depolarization-induced states. At present, the relative importance of ''pre-activated'' and ''in-activated'' states in potentiating inhibition by PIIIA is unclear.
2948-Pos Board B378 W493R Gain of Function Mutation in Atypical Cystic Fibrosis Rewires the Epithelial Sodium Channel Dynamics
Mahmoud Shobair 1 , Yan H. Dang 2 , Hong He 2 , Jack M. Stutts 2 , Nikolay V. Dokholyan 1 . 1 Biochemistry and Biophyiscs, UNC-CH, Chapel Hill, NC, USA, 2 Cystic Fibrosis Center, UNC-CH, Chapel Hill, NC, USA. Sodium absorption in epithelial cells is rate-limited by the epithelial sodium channel (ENaC) activity in lungs, kidney and the distal colon. Pathophysiological conditions, such as cystic fibrosis and Liddle syndrome, result from waterelectrolyte imbalance partly due to malfunction of ENaC's molecular regulation. The molecular mechanism(s) of pathologically implicated mutations in ENaC subunits are largely unknown due to absence of structural models for ENaC's oligomers. Here, we propose a dynamics-driven mechanism of the gain of function mutation aW493R implicated in atypical cystic fibrosis. We utilize a combination of discrete molecular dynamics simulations (DMD) of the extracellular region of ENaC's heterotrimer abg and functional data from whole-cell electrophysiology experiments. Structure-function studies suggest that tetramers and trimers are the major characterized functional oligomeric states of ENaC. Using the crystal structure of the acid sensing ion channel, ENaC's structural homolog in the ENaC/degenerin mechanosensitive ion channel family, we have constructed homology models of ENaC subunits alpha, beta and gamma, in addition to the heterotrimers abg, agb and the heterotetramer abag. Electrophysiology data show constitutive activity of aW493Rbg in oocytes indicated by higher open probability and elevated basal activity compared to WT. Our DMD simulation provides an allosteric framework, which agrees with experimental data. W493R rewires the electrostatically mediated inter-residue interaction network in close proximity to W493, resulting in widening of the pore geometry in the outer mouth of the pore in
